Skip to main content
. 2021 Jun 9;22:215. doi: 10.1186/s12882-021-02418-7

Table 2.

Comparison of clinical features and pregnancy outcomes between HDP-related and non-HDP Pr-AKI patients

Variables HDP-related
N = 48 (50 fetuses)
Non-HDP
N = 50 (50 fetuses)
P value
Age (years) 28.3 ± 5.1 26.9 ± 6.0 0.255
SBP (mmHg) 154.3 ± 19.0 110.6 ± 13.5 < 0.001
DBP (mmHg) 101.4 ± 15.3 69.3 ± 10.1 < 0.001
Serum ALB (g/L) 24.9 ± 5.6 27.5 ± 5.3 0.020
SCr (umol/L) 86(77–98) 90(78–111) 0.355a
Serum UA (umol/L) 477.1 ± 82.8 406.2 ± 115.7 0.001
Maternal death (n%) 2(4.0 %) 2(3.7 %) 1.000b

Gestational age at delivery

(in weeks)

37.1 ± 2.8 37.0 ± 4.0 0.858
Delivery via cesarean section (n%) 27(56.3 %) 15(31.3 %) 0.014
Pre-term birth (n%) 17(35.4 %) 12(26.1 %) 0.328
Stillbirth/neonatal death (n%) 6(13.6 %) 10(21.3 %) 0.339
Neonatal weight (g) 2770.2 ± 647.4 3023.8 ± 523.7 0.054
Apgar score at 1 min 7.8 ± 3.3 7.7 ± 3.7 0.923
IUGR (n%) 11(25.0 %) 1(2.3 %) 0.003b
Admission to NICU (n%) 11(22.0 %) 3(6.5 %) 0.019b
LBWI (n%) 17(37.8 %) 7(15.9 %) 0.020
Renal recovery on discharge (n%) 29(76.3 %) 35(85.4 %) 0.305

AKI acute kidney injury; HDP hypertensive disorders of pregnancy; SBP systolic blood pressure; DBP diastolic blood pressure; ALB albumin; SCr serum creatinine; UA uric acid; IUGR intrauterine growth restriction; LBWI low birth weight infant; NICU neonatal intensive care unit

Values for categorical variables were given as number (percentage); values for continuous variables were given as mean ± standard deviation or median (interquartile range)

P < 0.05 was considered to be statistically significant

a: Wilcoxon 2-sample tests

b: Fisher exact test